Discussion on the drug lag issue in the approval of new drugs in China between 2011 and 2021WU Wen-yu, WU Yi-fan, CHEN Xue-ying, CHEN Zi-ting, LIU Zuo-ren1073-1082
Clinical trial design and evaluation of chimeric antigen receptor T cell products in China and the United StatesZHAO Chen-yang, HUANG Yun-hong, LU Shuang, GAO Chen-yan1083-1088
Research progress of nano-formulation combined with microneedles for transdermal drug deliveryLI Hao-cheng, LU Zhi-yang, GAN Tian-tian, JIAN Wen-jie, FENG Jian-fang, JIN Yi, TU Liang-xing1089-1098
Clinical therapeutic value of a new generation of sodium-glucose cotransporter-2 inhibitor ertugliflozin in patients with diabetes and special populationsCHENG Qian, ZOU Shu-peng, SUN Ming-hui1099-1107
Monitoring and evaluation of tacrolimus concentration in serum of patients with systemic lupus erythematosusWANG Cheng-bin, LI Ying, YU Dan, ZHAO Ming-ming, ZHAO Li-mei1121-1127
The effect of Wuzhi capsules on blood concentration and clinical efficacy of tacrolimus in patients with nephrotic syndrome: a literature analysisZHANG Chun-yan, REN Xiao-lei, ZHANG Xiao-hong1128-1131
Clinical efficacy and safety of doxazosin mesylate combined with diclofenac sodium on postoperative bladder spasm after TURPNIAN Yong-qiang, CHEN Xing-xiang1132-1136
Basic profile and dilemma analysis of pediatric clinical research coordinators and discussion on the solutionFAN Wen-xiang, WANG Rui, LI Chun-mei, XU Chi, NI Shao-qing1137-1142